|
業務類別
|
Biotechnology |
|
業務概覽
|
Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associatedvirus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous,or IV, dosing. Its segment is developing and commercializing genetic medicine. |
| 公司地址
| 75 Hayden Avenue, Lexington, MA, USA, 02421 |
| 電話號碼
| +1 857 259-5340 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.voyagertherapeutics.com |
| 員工數量
| 141 |
| Dr. Nathan Jorgensen, M.B.A.,PhD |
Chief Financial Officer and Principal Accounting Officer |
-- |
21/04/2026 |
| Ms. Amy Quinlan |
Vice President, Finance |
-- |
21/04/2026 |
| Dr. Alfred W. Sandrock, Jr,M.D.,PhD |
Director, President and Chief Executive Officer |
美元 674.90K |
28/04/2026 |
| Mr. Gregory L. Shiferman |
Senior Vice President, General Counsel and Secretary |
-- |
28/04/2026 |
| Dr. Todd Carter, PhD |
Chief Scientific Officer |
-- |
28/04/2026 |
| Ms. Robin Swartz |
Chief Operating Officer |
美元 520.19K |
21/04/2026 |
|
|
| Mr. James A. Geraghty |
Independent Director |
28/04/2026 |
| Mr. Michael J. Higgins |
Chairman of the Board |
28/04/2026 |
| Dr. Glenn F. Pierce, M.D.,PhD |
Independent Director |
28/04/2026 |
| Dr. Steven E. Hyman, M.D. |
Independent Director |
28/04/2026 |
| Ms. Nancy Vitale |
Independent Director |
28/04/2026 |
| Dr. Alfred W. Sandrock, Jr,M.D.,PhD |
Director, President and Chief Executive Officer |
28/04/2026 |
| Dr. Grace E. Colon, PhD |
Independent Director |
28/04/2026 |
| Dr. George A. Scangos,PhD |
Independent Director |
28/04/2026 |
| Dr. Catherine J. Mackey, PhD |
Independent Director |
28/04/2026 |
| Dr. Jude Onyia, PhD |
Director |
28/04/2026 |
|
|
|
|
